* AmBisome® is a registered trademark of Gilead Sciences, Inc.
CRESEMBA® and Lexiscan are registered trademarks of Astellas US LLC.
Lexiscan® was developed in collaboration with Gilead Palo Alto, Inc. (formerly CV Therapeutics, Inc.).
Myrbetriq®, XOSPATA®, and XTANDI® are registered trademarks of Astellas Pharma Inc.
PADCEV® and the PADCEV device are trademarks jointly owned by Agensys, Inc., and Seagen Inc.
VEOZAH™ and the Wave logo are trademarks of Astellas US LLC.